Continued studies will deepen scientists’ understanding of virus-host interactions at the molecular level and also pave the way for developing better drugs to fight emerging viruses.

Flexible, high-throughput proteomics approach identifies protein modifications related to pancreatic stress and insulin production.

Scientists map how transitions from day to night control gene regulatory networks in cyanobacteria, revealing key orchestrators of metabolic switching.

Scientists uncover how cyanobacteria's circadian cycle controls carbon and energy metabolism, increasing carbon dioxide-to-bioproducts yields.

PNNL is hosting a scientific conference focused directly on understanding and predicting the collection of an organism’s traits.

Circadian rhythms of blue-green microbes offer new window into predictive phenomics—how to predict and control the traits of an organism.

This week at AAAS, PNNL scientists discuss phenomics and the factors that influence DNA instructions to bring about the world around us.

PNNL scientists use proteomics to unveil how high-density lipoproteins protect against cholesterol accumulation in the artery wall.

Computing and artificial intelligence aid scientists who seek to understand function-driven design and control of biological systems.

How to keep stray radiation from “shorting” superconducting qubits; a pair of studies shows where ionizing radiation is lurking and how to banish it.

Ryan Eddy, director of homeland security programs at PNNL, was recognized as one of 50 trailblazers by Homeland Security Today.

A launch from Cape Canaveral early today carried a PNNL experiment to space so scientists can learn more about radiation far above Earth.

The new PTM-Psi workflow opens the door for uncovering molecular insights within proteomics datasets.

Researchers designed ultra-low radiation cables to reduce background noise for highly sensitive neutrino and dark matter detectors.

PNNL’s Richard Saldanha will lead a new project to benchmark and validate models of cosmic ray exposure

Scientists developed a process (or pipeline) that combined molecular probes—a specific chemical that binds to microbes carrying out a particular function—with a method that isolated these cells from their complex community.

Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.

Glenn Fugate was selected to serve on the American Chemical Society's Science Committee.